Picture of Fortress Biotech logo

FBIO Fortress Biotech Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Annual cashflow statement for Fortress Biotech, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-102-103-165-214-154
Depreciation
Amortisation
Non-Cash Items8.4420.46.8127.832.5
Discontinued Operations
Unusual Items
Purchased R&D
Other Non-Cash Items
Changes in Working Capital-4.84-4.7836.4-0.715-12.5
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Cash from Operating Activities-95-83.7-117-179-128
Capital Expenditures-4.75-3.13-4.97-2.71-5.06
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items24.8-4.0445.5-20.22.96
Acquisition of Business
Sale of Business
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities20.1-7.1640.5-22.9-2.1
Financing Cash Flow Items76.141.511914.24.59
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities14717214975.332.7
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash71.881.673-127-97.6